Chemours (CC)
(Delayed Data from NYSE)
$19.57 USD
+0.34 (1.77%)
Updated Oct 4, 2024 04:00 PM ET
After-Market: $19.56 -0.01 (-0.05%) 7:58 PM ET
5-Strong Sell of 5 5
D Value F Growth A Momentum F VGM
Chemours (CC) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$25.56 | $35.00 | $18.00 | 32.92% |
Price Target
Based on short-term price targets offered by nine analysts, the average price target for Chemours comes to $25.56. The forecasts range from a low of $18.00 to a high of $35.00. The average price target represents an increase of 32.92% from the last closing price of $19.23.
Analyst Price Targets (9 )
Broker Rating
Chemours currently has an average brokerage recommendation (ABR) of 2.44 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by nine brokerage firms. The current ABR compares to an ABR of 2.44 a month ago based on nine recommendations.
Of the nine recommendations deriving the current ABR, two are Strong Buy and one is Buy. Strong Buy and Buy respectively account for 22.22% and 11.11% of all recommendations. A month ago, Strong Buy made up 22.22%, while Buy represented 11.11%.
Broker Rating Breakdown
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 2 | 2 | 2 | 2 | 2 |
Buy | 1 | 1 | 1 | 1 | 1 |
Hold | 6 | 6 | 6 | 6 | 6 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
ABR | 2.44 | 2.44 | 2.44 | 2.44 | 2.44 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
8/6/2024 | BMO Capital Markets | John P Mcnulty | Strong Buy | Strong Buy |
8/6/2024 | Not Identified | Not Identified | Hold | Hold |
7/9/2024 | UBS | Joshua Spector | Hold | Strong Buy |
6/28/2024 | Goldman Sachs | Duffy Fischer | Hold | Hold |
6/17/2024 | Not Identified | Not Identified | Moderate Buy | Moderate Buy |
6/7/2024 | Mizuho SecuritiesUSA | John Roberts | Not Available | Hold |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 2.44 |
ABR (Last week) | 2.44 |
# of Recs in ABR | 9 |
Average Target Price | $25.56 |
LT Growth Rate | NA |
Industry | Chemical - Diversified |
Industry Rank by ABR | 189 of 252 |
Current Quarter EPS Est: | 0.33 |
CC FAQs
The Chemours Company (CC) currently has an average brokerage recommendation (ABR) of 2.44 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 9 brokerage firms.
The average price target for The Chemours Company (CC) is $25.56. The current on short-term price targets is based on 4 reports.
The forecasts for The Chemours Company (CC) range from a low of $18 to a high of $35. The average price target represents a increase of $30.61 from the last closing price of $19.57.
The current UPSIDE for The Chemours Company (CC) is 30.61%
Based on short-term price targets offered by nine analysts, the average price target for Chemours comes to $25.56. The forecasts range from a low of $18.00 to a high of $35.00. The average price target represents an increase of 32.92% from the last closing price of $19.23.